20 May 2015
Opening Ceremony
09:30 Erkan İBİŞ
Rector of Ankara University
10:00 Morning Session: Antibody Technologies and use in Medicine – I
Ankara University Faculty of Pharmacy Pharmaceutical Technology Department, Tandoğan, Ankara
 10:00 – 10:45 Kim Jun JEONG
Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology
Recombinant antibodies: engineering and production in yeast and bacterial hosts.
 11:00 – 11:45 Serge MUYLDERMANS
Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel
Nanobodies: natural single-domain antibodies
12:00 Lunch
13:30 Afternoon Session: Antibody Technologies and use in Medicine – II
Izmir Biomedicine and Genome Center (iBG-izmir) Dokuz Eylul University, Izmir-TURKEY
 13:30 – 14:15 Hans J van der VLIET
Department of Medical Oncology, VU University Medical Center, The Netherlands
Bispecific antibodies in cancer immunotherapy
 14:30 – 15:15 Harald KOLMAR
Department of Biochemistry in the Department of Chemistry at the Technical University of Darmstadt
Therapeutic antibody engineering by high efficiency cell screening
Ankara University Biotechnology Institute, Ankara, Turkey
 15:30 – 16:15 Hakan AKBULUT
Department of Medical Oncology, Ankara University Faculty of Medicine
Clinical Use of Therapeutic Antibodies
 16:30 – 17:15 Özge ALPER
Founder of Alper Biotech LLC, Maryland (MD), USA
Antibodies in companion diagnostics
21 May 2015
Morning Session: Therapeutic Peptides: Expression and Engineering
Ankara University Biotechnology Institute
 09:30 – 10:15 Diethard MATTANOVICH
University of Natural Resources and Life Sciences, Vienna, Austria Department of Biotechnology and Austrian Centre of Industrial Biotechnology (ACIB)
Production of full lenght IgG and various fragment formats in the yeast Pichia pastoris
 10:30 – 11:15 Jan TAVERNIER
Department of Biochemistry, Cytokine Receptor Lab, VIB – UGent, Faculty of Medicine and Health Sciences, Belgium
Cell-specific targeting of cytokines: applications in cancer models
 11:30 – 12:15 Ismet DELİLOĞLU GÜRHAN
Ege University Faculty of Engineering Bioengineering Department
, Izmir, Turkey
Production and Optimization of Recombinant Humanized anti-Tumor Necrosis Factor alpha antibody Process
12:30 Lunch


13:30 – 15:00 Afternoon Session: Project Market – Gathering the State, Industrial and Academic Stakeholders
Hakan GÜRDAL, Prof.
Ankara University Faculty of Medicine, Department of Pharmacology
13:30 – 13:40 Devrim DEMİR DORA, Assoc Prof.
Ministery of Health, Pharmaceutical and Medical Device Agency, Biopharmaceuticals Registration Council,
Akdeniz University Medical Faculty Department of Pharmacology
13:40 – 13:50 Hakkı GÜRSÖZ, MD
Ministery of Health, Pharmaceutical and Medical Device Agency
13:50 – 14:00 Tolga DOĞRU, PharmD, MSc
Social Security Institution, General Health Insurence Directorate
14:00 – 14:10 Mehmet ÖZTÜRK, Prof.
Dokuz Eylül University Izmir Biomedicine and Genome Center (iGB-izmir)
14:10 – 14:20 İsmet DELİLOĞLU GÜRHAN, Prof.
Ege University Faculty of Engineering Bioengineering Department
14:20 – 14:30 Aydın ERENMEMİŞOĞLU
Erciyes University Faculty of Medicine, Department of Pharmacology
14:30 – 14:40 İrem YENİCE, PharmD, MSc, PhD
Sanovel Pharmaceuticals
14:40 – 14:50 Cem KOÇAK, ChE, MSc
Koçak Pharmaceuticals
14:50 – 15:00 Deniz ÜNVER, Bioeng. MSc
Nobel Pharmaceuticals
15:00 – 15:10 Turgut TOKGÖZ, MSc
Pharmaceutical Manufacturers Association of Turkey
15:10 – 15:30 Coffee Break
15:30 – 16:30 Round Table Discussion
17:00 – 18:00 Graduation Ceremony
18:00 – 19:30 Coctail